HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome
Alexandra Laberko(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Anna Shcherbina, Ingo Müller(Universität Hamburg), Sarah Maier(Technische Universität Dresden), В. И. Бурлаков(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Roderick Skinner(Royal Victoria Infirmary), Kai Lehmberg(Universität Hamburg), Deepti Suri(Post Graduate Institute of Medical Education and Research), Галина Новичкова(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Dirk Holzinger(University of Duisburg-Essen), Dmitry Balashov(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), А. Л. Козлова(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Mario Abinun(North Tyneside General Hospital), Andrew R. Gennery(Newcastle upon Tyne Hospitals NHS Foundation Trust)
Cited by 29
Related Papers
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Rational Extended Thermodynamics
|Springer Tracts in Natural Philosophy|1998|1.3k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
|Nature Genetics|2001|819
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721